Search

Search Constraints

You searched for: Author/Creator Kato, Yoshiro

Search Results

1. Alterations of retinal thickness measured by optical coherence tomography correlate with neurophysiological measures in diabetic polyneuropathy. Issue 8 (30th December 2020)

2. Case of ketoacidosis by a sodium‐glucose cotransporter 2 inhibitor in a diabetic patient with a low‐carbohydrate diet. Issue 5 (20th February 2015)

4. Lipopolysaccharide impairs insulin sensitivity via activation of phosphoinositide 3-kinase in adipocytes. (April 2014)

5. Neuroretinal dysfunction revealed by a flicker electroretinogram correlated with peripheral nerve dysfunction and parameters of atherosclerosis in patients with diabetes. Issue 7 (18th December 2020)

6. Omega‐3 polyunsaturated fatty acids exert anti‐oxidant effects through the nuclear factor (erythroid‐derived 2)‐related factor 2 pathway in immortalized mouse Schwann cells. Issue 3 (13th October 2018)

7. Once-weekly DPP-4 inhibitors: The clinical efficacy and treatment satisfaction in 51 Japanese patients with type 2 diabetes mellitus. (October 2016)

8. Performance comparison of average daily risk range obtained by continuous glucose monitoring and self-monitoring of blood glucose in diabetic outpatients. (October 2016)

9. Point‐of‐care nerve conduction device predicts the severity of diabetic polyneuropathy: A quantitative, but easy‐to‐use, prediction model. Issue 4 (14th September 2020)

10. Ranirestat Improved Nerve Conduction Velocities, Sensory Perception, and Intraepidermal Nerve Fiber Density in Rats with Overt Diabetic Polyneuropathy. (18th November 2019)